More and more companies are venturing into medical devices, drugs or biologics in an effort to diversify or to promote new biotechnologies. At the same time, the United States government is taking a more active role in regulating the manufacturers, providers and payers in the healthcare industry. The collision of these two trends – increased interest in marketing healthcare products along with increased government involvement in regulation and enforcement – require companies to attain FDA regulatory compliance and prevent fraud and abuse violations in order to be successful in this industry and avoid multi-million dollar fines and penalties.
In this audio conference, the speaker will address the basic things that people and companies need to know about dealing with the FDA and succeeding in the life sciences industry.
This event is presented by Bethany Gilbert of Hodgson Russ. To learn more, please visit www.fxconferences.com.
